Dongmin Jung
Overview
Explore the profile of Dongmin Jung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
1785
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim C, Kim H, Jung D, Kim H, Park Y, Han M, et al.
Sci Rep
. 2024 Mar;
14(1):7134.
PMID: 38532018
We aimed to investigate the deliverability of dynamic conformal arc therapy (DCAT) by gantry wobble owing to the intrinsic inter-segment break of the Elekta linear accelerator (LINAC) and its adverse...
2.
Park J, Lim J, Jung I, Heo S, Park J, Chang Y, et al.
Cell
. 2021 Feb;
184(4):1047-1063.e23.
PMID: 33539780
DNA has not been utilized to record temporal information, although DNA has been used to record biological information and to compute mathematical problems. Here, we found that indel generation by...
3.
Kim M, Kim J, Lee J, Choi J, Jung D, Cho H, et al.
Br J Cancer
. 2020 Jun;
123(6):1041.
PMID: 32572173
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
4.
Kim M, Kim J, Lee J, Choi J, Jung D, Cho H, et al.
Br J Cancer
. 2020 Apr;
122(11):1649-1660.
PMID: 32235905
Background: Oropharyngeal cancer (OPC) exhibits diverse immunological properties; however, their implications for immunotherapy are unknown. Methods: We analysed 37 surgically resected and nine recurrent or metastatic anti-programmed death-1 (PD-1)/programmed death-ligand...
5.
Ge S, Jung D, Yao R
Bioinformatics
. 2019 Dec;
36(8):2628-2629.
PMID: 31882993
Motivation: Gene lists are routinely produced from various omic studies. Enrichment analysis can link these gene lists with underlying molecular pathways and functional categories such as gene ontology (GO) and...
6.
Kim S, Lee J, Kim D, Joo H, Yun M, Jung D, et al.
Sci Rep
. 2019 Dec;
9(1):19909.
PMID: 31882684
Adequate preclinical model and model establishment procedure are required to accelerate translational research in lung cancer. We streamlined a protocol for establishing patient-derived cells (PDC) and identified effective targeted therapies...
7.
Chun Y, Choi J, Hong M, Jung D, Son H, Cho E, et al.
PLoS One
. 2019 Nov;
14(11):e0224379.
PMID: 31765373
The treatment of Lung adenocarcinoma (LUAD) could benefit from the incorporation of precision medicine. This study was to identify cancer-related genetic alterations by next generation sequencing (NGS) in resected LUAD...
8.
Kim H, Kim Y, Lee S, Min S, Bae J, Choi J, et al.
Sci Adv
. 2019 Nov;
5(11):eaax9249.
PMID: 31723604
We evaluated SpCas9 activities at 12,832 target sequences using a high-throughput approach based on a human cell library containing single-guide RNA-encoding and target sequence pairs. Deep learning-based training on this...
9.
Lim S, Choi J, Hong M, Jung D, Lee C, Park S, et al.
Lung Cancer
. 2019 Apr;
131:139-146.
PMID: 31027691
Objectives: Radon, a natural radiation, is the leading environmental cause of lung cancer in never-smokers. However, the radon exposure impact on the mutational landscape and tumor mutation burden (TMB) of...
10.
Ahn B, Pyo K, Xin C, Jung D, Shim H, Lee C, et al.
J Cancer Res Clin Oncol
. 2019 Mar;
145(6):1613-1623.
PMID: 30911841
Purpose: Immune checkpoint inhibitors (ICI) have shown marked responses in patients with non-small cell lung cancer (NSCLC) in clinical trials. However, because such trials comprise cohorts selected based on specific...